LENZ Therapeutics (LENZ) Prepaid Assets (2020 - 2026)
LENZ Therapeutics' (LENZ) quarterly Prepaid Assets came in at $6.1 million in Q1 2026, up 62.93% year-on-year from $3.8 million in Q1 2025, and up 5.88% on a QoQ basis from $5.8 million in Q4 2025.
LENZ Therapeutics (LENZ) Prepaid Assets (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Prepaid Assets data on file, last reported at $6.1 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 62.93% year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $6.1 million, a 62.93% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 109.16% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.1 million, up from $5.8 million in the prior quarter.
- Over the last five years, Prepaid Assets for LENZ reached as high as $7.1 million in Q4 2022 and fell as low as $181000.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $3.7 million across 5 years, with a median of $3.5 million in 2024.
- Across the five-year window, Prepaid Assets plunged 93.14% in 2022 and soared 1490.06% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $7.1 million in 2022, then sank by 79.68% to $1.4 million in 2023, then jumped by 91.24% to $2.8 million in 2024, then jumped by 109.16% to $5.8 million in 2025, then gained by 5.88% to $6.1 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $6.1 million in Q1 2026, $5.8 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.14 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 4.78 Mn |
| Jun 30, 2023 | 2.88 Mn |
| Mar 31, 2023 | 3.48 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 4.57 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 6.28 Mn |
| Jun 30, 2021 | 2.64 Mn |